Cansino Biologics, Inc. Class ASSE: 688185

"Cansino Biologics Inc."Announcement on Abnormal Fluctuations in Stock Trading

Aug 22, 2026 · Issued by Cansino Biologics, Inc. Class A via Shanghai Stock Exchange

Announcement on Abnormal Fluctuations in Stock Trading

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Cansino Biologics, Inc. Class A

"Cansino Biologics Inc."Announcement on Obtaining Drug Registration Certificate for Adsorbed Tetanus VaccineAug 21
"Cansino Biologics Inc."Announcement on Voluntary Disclosure of Acceptance of the Drug Registration Application for Adsorbed Tetanus, Diphtheria and Pertussis (Acellular, Five Components) Combined Vaccine (For Persons Aged 6 and Above)Aug 17
CanSino Biologics: CanSinoBIO's Menhycia® Application Accepted by China's NMPA for Expanded Use in Population Aged 3 Months to 17 YearsJul 19
CanSino Biologics: CanSinoBIO's MCV4 Receives Registration Approval in Argentina, Expanding Global ReachJun 25

All Cansino Biologics, Inc. Class A news releases